Epigral Ltd. (EPIGRAL) - Total Liabilities

Latest as of September 2025: Rs11.35 Billion INR ≈ $122.78 Million USD

Based on the latest financial reports, Epigral Ltd. (EPIGRAL) has total liabilities worth Rs11.35 Billion INR (≈ $122.78 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how efficiently does Epigral Ltd. generate cash to assess how effectively this company generates cash.

Epigral Ltd. - Total Liabilities Trend (2015–2025)

This chart illustrates how Epigral Ltd.'s total liabilities have evolved over time, based on quarterly financial data. Check EPIGRAL asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Epigral Ltd. Competitors by Total Liabilities

The table below lists competitors of Epigral Ltd. ranked by their total liabilities.

Company	Country	Total Liabilities
Ningbo MedicalSystem Biotechnology Co Ltd SHE:300439	China	CN¥706.76 Million
Qingdao Liqun Department Store Group Co Ltd SHG:601366	China	CN¥11.36 Billion
AMERISAFE Inc NASDAQ:AMSF	USA	$-907.67 Million
Qinghai Huzhu Barley Wine Co Ltd SHE:002646	China	CN¥446.82 Million
Indointernet Tbk PT JK:EDGE	Indonesia	Rp2.14 Trillion
MERSEN UNSP.ADR 1/5 EO 2 F:CBE0	Germany	€1.01 Billion
COGNYTE SOFTWARE LTD F:81M	Germany	€292.20 Million
Peoples Fin NASDAQ:PFIS	USA	$4.75 Billion

Liability Composition Analysis (2015–2025)

This chart breaks down Epigral Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see EPIGRAL market cap.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.31	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.54	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.35	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Epigral Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Epigral Ltd. (2015–2025)

The table below shows the annual total liabilities of Epigral Ltd. from 2015 to 2025.

Year	Total Liabilities	Change
2025-03-31	Rs12.48 Billion ≈ $134.96 Million	-18.98%
2024-03-31	Rs15.40 Billion ≈ $166.57 Million	+12.99%
2023-03-31	Rs13.63 Billion ≈ $147.42 Million	-2.47%
2022-03-31	Rs13.98 Billion ≈ $151.16 Million	+82.81%
2021-03-31	Rs7.65 Billion ≈ $82.69 Million	+10.81%
2020-03-31	Rs6.90 Billion ≈ $74.62 Million	+25.12%
2019-03-31	Rs5.51 Billion ≈ $59.64 Million	+259.21%
2018-03-31	Rs1.54 Billion ≈ $16.60 Million	-7.43%
2017-03-31	Rs1.66 Billion ≈ $17.93 Million	-32.24%
2016-03-31	Rs2.45 Billion ≈ $26.47 Million	-22.05%
2015-03-31	Rs3.14 Billion ≈ $33.96 Million	--

About Epigral Ltd.

NSE:EPIGRAL India Chemicals

Market Cap

$567.17 Million

Rs52.44 Billion INR

Market Cap Rank

#11886 Global

#559 in India

Share Price

Rs1215.65

Change (1 day)

+1.77%

52-Week Range

Rs810.45 - Rs2088.70

All Time High

Rs2344.35